Found: 13
Select item for more details and to access through your institution.
Inflammatory and senescence‐associated mediators affect the persistence of humoral response to COVID‐19 mRNA vaccination in transfusion‐dependent beta‐thalassemic patients.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 6, p. E145, doi. 10.1002/ajh.26905
- By:
- Publication type:
- Article
Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. E75, doi. 10.1002/ajh.26429
- By:
- Publication type:
- Article
Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 634, doi. 10.1002/ajh.24024
- By:
- Publication type:
- Article
Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 7, p. 732, doi. 10.1002/ajh.23219
- By:
- Publication type:
- Article
Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 2, p. 124, doi. 10.1111/ejh.12989
- By:
- Publication type:
- Article
Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy.
- Published in:
- Journal of Cardiovascular Magnetic Resonance (BioMed Central), 2013, v. 15, n. 1, p. 1, doi. 10.1186/1532-429X-15-1
- By:
- Publication type:
- Article
Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2018, v. 19, n. 3, p. 299, doi. 10.1093/ehjci/jex012
- By:
- Publication type:
- Article
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 2, p. 274, doi. 10.1111/j.1365-2141.2012.09152.x
- By:
- Publication type:
- Article
Long‐term sequential deferiprone and deferasirox therapy in transfusion‐dependent thalassaemia patients: a prospective clinical trial.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 6, p. e209, doi. 10.1111/bjh.16101
- By:
- Publication type:
- Article
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 1, p. 124, doi. 10.1111/bjh.14381
- By:
- Publication type:
- Article
Detection of Early Cardiac Dysfunction in Patients with Beta Thalassemia by Tissue Doppler Echocardiography.
- Published in:
- Echocardiography, 2011, v. 28, n. 2, p. 175, doi. 10.1111/j.1540-8175.2010.01270.x
- By:
- Publication type:
- Article
A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation.
- Published in:
- 2022
- By:
- Publication type:
- Case Study